相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Tumor-associated CD3- and CD8-positive immune cells in colorectal cancer: The additional prognostic value of CD8+-to-CD3+ ratio remains debatable
Jussi Kasurinen et al.
TUMOR BIOLOGY (2022)
Molecular and Clinical Characterization of LAG3 in Breast Cancer Through 2994 Samples
Qiang Liu et al.
FRONTIERS IN IMMUNOLOGY (2021)
Right and Left Colorectal Cancer: Differences in Post-Surgical-Care Outcomes and Survival in Elderly Patients
Irene Miron Fernandez et al.
CANCERS (2021)
LAG-3 Expression Predicts Outcome in Stage II Colon Cancer
Gaelle Rhyner Agocs et al.
JOURNAL OF PERSONALIZED MEDICINE (2021)
LAG-3 is expressed on a majority of tumor infiltrating lymphocytes in pediatric Hodgkin lymphoma
Scott Moerdler et al.
LEUKEMIA & LYMPHOMA (2021)
The Immunoscore: Colon Cancer and Beyond
Helen K. Angell et al.
CLINICAL CANCER RESEARCH (2020)
Lymphocyte Activation Gene (LAG)-3 Is Associated With Mucosal Inflammation and Disease Activity in Ulcerative Colitis
Stephanie M. Slevin et al.
JOURNAL OF CROHNS & COLITIS (2020)
Immunoscore and its introduction in clinical practice
Jerome Galon et al.
QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)
Importance of CD45RO+tumor-infiltrating lymphocytes in post-operative survival of breast cancer patients
Simin Ahmadvand et al.
CELLULAR ONCOLOGY (2019)
Targeting immune pathways in breast cancer: review of the prognostic utility of TILs in early stage triple negative breast cancer (TNBC)
Elizabeth F Blackley et al.
BREAST (2019)
Prognostic Value of Lymphocyte-Activation Gene 3 (LAG3) in Cancer: A Meta-Analysis
Ramy R. Saleh et al.
FRONTIERS IN ONCOLOGY (2019)
Fibrinogen-like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3
Jun Wang et al.
CELL (2019)
LAG-3 expression on tumor-infiltrating T cells in soft tissue sarcoma correlates with poor survival
Yi Que et al.
CANCER BIOLOGY & MEDICINE (2019)
Combination of nanotechnology with vascular targeting agents for effective cancer therapy
Rana Jahanban-Esfahlan et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
LAG-3 in Non-Small-cell Lung Cancer: Expression in Primary Tumors and Metastatic Lymph Nodes Is Associated With Improved Survival
Sigurd M. Hald et al.
CLINICAL LUNG CANCER (2018)
Tumor-infiltrating CD45RO+ memory cells correlate with favorable prognosis in patients with lung adenocarcinoma
Zhangguo Hu et al.
JOURNAL OF THORACIC DISEASE (2018)
Induction and transcriptional regulation of the co-inhibitory gene module in T cells
Norio Chihara et al.
NATURE (2018)
Global patterns and trends in colorectal cancer incidence and mortality
Melina Arnold et al.
GUT (2017)
LAG3 (CD223) as a cancer immunotherapy target
Lawrence P. Andrews et al.
IMMUNOLOGICAL REVIEWS (2017)
The EGR2 targets LAG-3 and 4-1BB describe and regulate dysfunctional antigen-specific CD8+ T cells in the tumor microenvironment
Jason B. Williams et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Tumor-infiltrating CD45RO+ Memory T Lymphocytes Predict Favorable Clinical Outcome in Solid Tumors
Guoming Hu et al.
SCIENTIFIC REPORTS (2017)
LAG-3+tumor infiltrating lymphocytes in breast cancer: clinical correlates and association with PD-1/PD-L1+tumors
S. Burugu et al.
ANNALS OF ONCOLOGY (2017)
Expansion of Tumor-reactive T Cells From Patients With Pancreatic Cancer
Qingda Meng et al.
JOURNAL OF IMMUNOTHERAPY (2016)
Prognostic Significance of Tumor-infiltrating CD8+ or CD3+ T Lymphocytes and Interleukin-2 Expression in Radically Resected Non-small Cell Lung Cancer
Chuntao Tian et al.
CHINESE MEDICAL JOURNAL (2015)
Is right-sided colon cancer different to left-sided colorectal cancer? - A systematic review
G. H. Lee et al.
EJSO (2015)
LAG3 and PD1 co-inhibitory molecules collaborate to limit CD8+ T cell signaling and dampen antitumor immunity in a murine ovarian cancer model
Ruea-Yea Huang et al.
ONCOTARGET (2015)
The effect of immune microenvironment on the progression and prognosis of colorectal cancer
Jinxiang Chen et al.
MEDICAL ONCOLOGY (2014)
Clinical impact of tumor-infiltrating CD45RO+ memory T cells on human gastric cancer
Kohei Wakatsuki et al.
ONCOLOGY REPORTS (2013)
Has the new TNM classification for colorectal cancer improved care?
Iris D. Nagtegaal et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
The immune contexture in human tumours: impact on clinical outcome
Wolf Herman Fridman et al.
NATURE REVIEWS CANCER (2012)
Prognostic significance of CD45RO+memory T cells in renal cell carcinoma
K. Hotta et al.
BRITISH JOURNAL OF CANCER (2011)
MHC Class II Engagement by Its Ligand LAG-3 (CD223) Contributes to Melanoma Resistance to Apoptosis
Patrice Hemon et al.
JOURNAL OF IMMUNOLOGY (2011)
SPARC, FOXP3, CD8 and CD45 Correlation with Disease Recurrence and Long-Term Disease-Free Survival in Colorectal Cancer
Angela Chew et al.
PLOS ONE (2011)
Co-expression of nuclear and cytoplasmic HMGB1 is inversely associated with infiltration of CD45RO+T cells and prognosis in patients with stage IIIB colon cancer
Rui-Qing Peng et al.
BMC CANCER (2010)
Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review
Katsuhiko Nosho et al.
JOURNAL OF PATHOLOGY (2010)
Immune infiltration in human tumors: a prognostic factor that should not be ignored
F. Pages et al.
ONCOGENE (2010)
Functionally Distinct LAG-3 and PD-1 Subsets on Activated and Chronically Stimulated CD8 T Cells
Joseph F. Grosso et al.
JOURNAL OF IMMUNOLOGY (2009)
Prognostic implications of type and density of tumour-infiltrating lymphocytes in gastric cancer
H. E. Lee et al.
BRITISH JOURNAL OF CANCER (2008)
Expression of LAG-3 by tumor-infiltrating lymphocytes is coincident with the suppression of latent membrane antigen-specific CD8+ T-cell function in Hodgkin lymphoma patients
Maher K. Gandhi et al.
BLOOD (2006)
Tumor-infiltrating T lymphocytes: friends or foes?
P Yu et al.
LABORATORY INVESTIGATION (2006)
Accumulation of CD45RO+ cells in peritoneal carcinomatous fluid favours survival of ovarian carcinoma patients
I Kryczek et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2002)
分享论文
